Open AccessPHARMACOECONOMIC ANALYSIS OF THE CONVENTIONAL PHARMACOTHERAPYOF dEEP VEIN THROMBOSIS
Author(s) -
В. И. Петров,
В. И. Петров,
О. В. Шаталова,
О. В. Шаталова,
О Н Смусева,
О Н Смусева,
В. С. Горбатенко,
В. С. Горбатенко
Publication year - 2015
Publication title -
vestnik severo-zapadnogo gosudarstvennogo medicinskogo universiteta im. i.i. mečnikova
Language(s) - English
Resource type - Journals
eISSN - 2618-9704
pISSN - 2618-7116
DOI - 10.17816/mechnikov201571128-133
Subject(s) - medicine , deep vein , cost analysis , economic analysis , thrombosis , warfarin , total cost , indirect costs , economic cost , cost–benefit analysis , surgery , intensive care medicine , economics , engineering , agricultural economics , reliability engineering , atrial fibrillation , ecology , neoclassical economics , biology , microeconomics , accounting
The cost analysis of treatment of deep vein thrombosis was performed in conventional therapy. The estimation of the cost of treatment of DVT in conventional treatment was done, using clinical-economic analysis - the «cost of illness» (COI). The study took into account only the direct costs of state and patients during 6 month treatment course. The cost analysis of DVT in conventional treatment was held, the economic burden of DVT is 1,8 billion rubles, in structure of cost it is occupying 98%. The cost of purchase of warfarin is occupying only 2%. At the present stage DVT and its complications are the serious problem, spending resources. In the cost`s structure of DVT outgoings of hospital treatment are 83%, if we reduce hospitalization costs, we can reduce state costs of DVT treatment.